Interbody fusion cage is an implantable medical device utilized to maintain the forminal height of the spine. Interbody fusion cages are interleaved between the spinal cords when the space between the discs gets diverted. Materials used for manufacturing interbody fusion cages are titanium, carbon fiber, or allograft femur. These devices are either cylindrical or square-shaped, and are mostly threaded. These cages can be crammed with autologous bone material in order to promote artificial ankylosis or arthrodesis.
Factors, such as, growth in geriatric population and high incidence rate of spinal injuries and sports injuries have boosted the growth of the interbody fusion cage market. Additionally, there has been a rise in demand for surgeries pertaining to interbody fusion cage owing to benefits that permit the surgeon to directly decompress nerves and reconstruct the spine, thereby leading to market growth. Also, rising consumer awareness regarding this treatment in both developed and developing countries is fuelling the market growth. However, restraints, such as, stringent rules and regulations pertaining to the use of these devices, high costs associated with spinal fusion surgeries, and lack of trained professionals are anticipated to hamper the growth of this market during the forecast period. Nevertheless, introduction of novel interbody fusion cages provided with new compatible materials is likely to create more opportunities in the market.
The global interbody fusion cage market can be segmented on the basis of product, surgery type, end-user, and region. On the basis of product, the global interbody fusion cage market can be divided into lumbar, cervical, thoraco-lumbar, and thoracic. Depending on the type of surgery, the market can be classified into lateral, anterior, posterior, and transforaminal. Based on end-user, the interbody fusion cage market can be divided into hospital, clinic, medical center, and others. In terms of geography, the market can be categorized into five regions, viz. North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.
Among products, the thoraco-lumbar segment commands a major share of the global interbody fusion cage market. The thoraco-lumbar spinal region is the maximum-affected area by diseases and injuries, such as, tumor, disc degenerative disease, trauma, and infectious diseases and requires treatment by spinal interbody fusion cage technique. Thus, this factor is promoting the growth of the interbody fusion cage market.
Based on type of surgery, the anterior surgery segment commanded a major share in 2017. It is easy as well as convenient to implant larger bone cages and grafts, thereby enabling improved initial stability as well as compression of the fusion construct.
On the basis of geography, North America accounts for a leading share of the interbody fusion cage market, in terms of revenue, followed by Europe. The interbody fusion cage market in the emerging countries, such as, China, South Korea, Brazil, and India is expected to grow significantly during the next five years. The market is likely to be dominated by North America and Europe during the forecast period. The prominent market share of North America can be attributed to the well-established health care infrastructure and rise in adoption rate of interbody fusion cage across various health care settings in the region.
The interbody fusion cage market in Asia Pacific market is expected to witness a significant growth due to increase in geriatric population, high prevalence of spinal injuries, investments made by market players in the emerging countries, such as, China and India, and rise in consumer awareness about this treatment in the region. Other regions, such as, Middle East & Africa and Latin America are expected to be the prospective markets in the near future.
Major players operating in the interbody fusion cage market include Benvenue Medical, Inc., Aurora Spine, Inc., Ulrich Medicals USA, NuVasive, Inc., B. Braun Melsungen AG, Orthofix International, N.V., Medtronic, plc, Prodorth, Zimmer Biomet, Inc., and Johnson & Johnson (DePuy Synthesis). Other players in this sector include Precision Spine USA, Spineart France, Biomet USA, Globus Medical USA, Medacta Switzerland, and K2M USA.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.